Cargando…

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy

Endogenous control mechanisms, including immune checkpoints and immunosuppressive cells, are exploited in the process of tumorigenesis to weaken the anti-tumor immune response. Cancer treatment by chemotherapy or immune checkpoint inhibition can lead to changes of checkpoint expression, which influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puntigam, Lisa K., Jeske, Sandra S., Götz, Marlies, Greiner, Jochen, Laban, Simon, Theodoraki, Marie-Nicole, Doescher, Johannes, Weissinger, Stephanie E., Brunner, Cornelia, Hoffmann, Thomas K., Schuler, Patrick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432918/ https://www.ncbi.nlm.nih.gov/pubmed/32707816 http://dx.doi.org/10.3390/ijms21155181

Ejemplares similares

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice
por: Brand, Matthias, et al.
Publicado: (2020)

Circulating Exosomes Inhibit B Cell Proliferation and Activity
por: Schroeder, Jan C., et al.
Publicado: (2020)

Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma
por: Jeske, S. S., et al.
Publicado: (2020)

NF-κB and Its Role in Checkpoint Control
por: Betzler, Annika C., et al.
Publicado: (2020)

BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
por: Betzler, Annika C., et al.
Publicado: (2023)

Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients
por: Theodoraki, M.-N., et al.
Publicado: (2021)

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Kötting, Charlotte, et al.
Publicado: (2021)

The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma
por: Ziebart, Andreas, et al.
Publicado: (2017)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions
por: von Witzleben, Adrian, et al.
Publicado: (2022)

Adenosine-producing regulatory B cells in head and neck cancer
por: Jeske, Sandra S., et al.
Publicado: (2020)

Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer
por: Beccard, Inga J., et al.
Publicado: (2020)

P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Greiner, Jochen, et al.
Publicado: (2023)

Increasing Role of Targeted Immunotherapies in the Treatment of AML
por: Greiner, Jochen, et al.
Publicado: (2022)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
por: Zhang, Lu, et al.
Publicado: (2012)

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy
por: Laban, Simon, et al.
Publicado: (2017)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck
por: Doescher, Johannes, et al.
Publicado: (2022)

Planned neck dissection following chemo-radiotherapy in advanced HNSCC
por: Gupta, Tejpal, et al.
Publicado: (2004)

Influence of Bruton’s Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Leichtle, Franziska, et al.
Publicado: (2023)

In-situ formed thermosensitive hydrogel amplifies statin-mediated immune checkpoint blockade for coordinated tumor chemo-immunotherapy
por: Liu, Zefan, et al.
Publicado: (2023)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
por: Saddawi-Konefka, Robert, et al.
Publicado: (2022)

Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma
por: Mytilineos, Daphne, et al.
Publicado: (2020)

Treatment dependent impact of plasma-derived exosomes from head and neck cancer patients on the epithelial-to-mesenchymal transition
por: Hofmann, Linda, et al.
Publicado: (2023)

Immune checkpoints, their control by immunotherapy and ovarian cancer
por: Bose, Chinmoy K.
Publicado: (2017)

Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer
por: Wei, Jiaojie, et al.
Publicado: (2019)

The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
por: Hassanian, Hamidreza, et al.
Publicado: (2022)

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
por: Liang, Jingjing, et al.
Publicado: (2020)

A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells
por: Guinn, Barbara-ann, et al.
Publicado: (2023)

Immune checkpoint signaling and cancer immunotherapy
por: He, Xing, et al.
Publicado: (2020)

Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)

A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
por: Ding, Yinghe, et al.
Publicado: (2023)

CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients’ plasma as potential noninvasive biomarkers of disease activity
por: Theodoraki, Marie-Nicole, et al.
Publicado: (2020)

Review of biomarkers for response to immunotherapy in HNSCC microenvironment
por: Chen, Shaoshi, et al.
Publicado: (2023)

Changes in Gene Expression Patterns in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Under Chemoradiotherapy Depend on Response
por: Doescher, Johannes, et al.
Publicado: (2022)

The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer
por: Hofmann, Linda, et al.
Publicado: (2020)

Differential Requirement of Vav Proteins for Btk-dependent and –Independent Signaling During B Cell Development
por: Betzler, Annika C., et al.
Publicado: (2022)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vfi4cf0c4d91gbg8a0o6oq1igg